XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 2,381,087 $ 1,989,974
Accounts receivable, less allowances of $5,000 in 2019 and 2018 245,999 400,759
Notes & accounts receivables and deposits - related parties 1,269,527 151,222
Inventories    
Finished goods 1,959,535 2,460,563
Raw materials 176,481 372,865
Sales aids and promotional materials 127,653 121,519
Total inventories 2,263,669 2,954,947
Refundable income taxes 20,794 22,712
Assets held for sale 2,124,939
Prepaid expenses and other current assets 693,749 441,453
Total current assets 6,874,825 8,086,006
Other assets 388,655 338,974
Notes and accounts receivables - related parties 2,897,249 1,282,072
Operating lease right-to-use assets 394,287
Intangible assets, net 1,891,767 1,948,263
Equity investment 505,000
Property, plant and equipment:    
Land and land improvements 905,190 905,190
Building 10,103,321 9,964,523
Office & other equipment 1,226,971 1,337,911
Computer equipment & software 2,227,664 2,212,935
Property, plant and equipment, Gross, Total 14,463,146 14,420,559
Less: Accumulated depreciation 9,813,657 9,722,009
Net property, plant and equipment 4,649,489 4,698,550
Total assets 17,601,272 16,353,865
Current liabilities:    
Trade accounts payable and other accrued expenses 2,171,407 2,105,814
Distributors' commissions payable 855,664 1,030,948
Sales taxes payable 168,430 195,802
Payroll and payroll taxes payable 271,927 210,288
Total accounts payable and accrued expenses 3,467,428 3,542,852
Income taxes payable 77,534 35,304
Deferred revenue 365,447 337,234
Operating lease liabilities, current 229,700
Deferred rent liability 187,500
Revolving line of credit 500,000
Total current liabilities 4,827,609 3,915,390
Noncurrent liabilities:    
Operating lease liabilities, noncurrent 158,751
Other noncurrent liabilities 483,750 445,611
Total noncurrent liabilities 642,501 445,611
Stockholders' equity:    
Preferred stock, par value $.001 per share; 500,000 shares authorized; -0- shares issued and outstanding in 2019 and 2018 0 0
Common stock, par value $.001 per share; 5,000,000 authorized; 2,110,013 shares issued and 1,746,449 shares outstanding as of 3/31/2019; 2,110,013 shares issued and 1,845,160 shares outstanding as of 12/31/2018 2,110 2,110
Additional paid-in capital 30,627,853 30,622,547
Accumulated deficit (11,687,494) (12,311,138)
Accumulated other comprehensive loss:    
Foreign currency translation adjustment (959,884) (982,095)
Treasury stock (5,851,423) (5,338,560)
Total stockholders' equity 12,131,162 11,992,864
Total liabilities and stockholders' equity $ 17,601,272 $ 16,353,865